miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Di Martino, Maria Teresa, Riillo, Caterina, Scionti, Francesca, Grillone, Katia, Polerà, Nicoletta, Caracciolo, Daniele, Arbitrio, Mariamena, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036682/
https://ncbi.nlm.nih.gov/pubmed/33808190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars